Lisa A. Peterson
Subscribe to Lisa A. Peterson's PostsLisa A. Peterson focuses her practice on antitrust, regulatory and litigation matters. She assists clients across a variety of industries and has represented numerous clients in the health care, pharmaceutical, and biotechnology industries. Lisa advises clients on mergers and acquisitions, including obtaining clearance from the Federal Trade Commission (FTC) and Department of Justice (DOJ), as well as counsels clients on issues regarding antitrust compliance, pricing, and distribution. She also counsels clients on cartel prosecutions and defenses, including government investigations and the initiation and defense of civil class action litigation. Read Lisa Peterson's full bio.
Pay-for-delay to Stay FTC’s Top Priority
By Lisa A. Peterson on Nov 18, 2013
Posted In FTC Developments
In a recent interview, Federal Trade Commission (FTC) Bureau of Competition chairwoman Deborah Feinstein announced that targeting pay-for-delay arrangements by pharmaceutical companies would continue as a top priority for the FTC. Pay-for-delay deals arise when pharmaceutical companies marketing branded drugs pay a pharmaceutical company to enter into a patent settlement with manufactures of generic drugs....
Continue Reading
Healthcare Provider Fees May Constitute Kickbacks Even Without Direct Referrals
By Lisa A. Peterson on Nov 15, 2013
Posted In Healthcare Antitrust
In a recent advisory opinion, the Department of Health and Human Services inspector general warned health care providers about entering into contracts that may generate illegal kickbacks and result in administrative penalties. An unnamed anesthesiology provider requested advice regarding a proposed contract with an in-hospital psychiatric service. Currently, the anesthesiology provider is the exclusive provider...
Continue Reading
